Navigation Links
MDA awards $13.5 million in grants for research treatments for neuromuscular diseases
Date:2/8/2011

TUCSON, Ariz., Feb. 8, 2011 The Muscular Dystrophy Association today awarded 44 grants totaling $13.5 million to support new research to advance understanding of disease processes and to uncover new strategies for treating muscular dystrophies, ALS and other related neuromuscular diseases affecting more than a million Americans. The vital research funding was made possible by generous public support of the MDA Labor Day Telethon.

"MDA-supported researchers have long led the way in advancing understanding of, and developing therapeutic strategies for, neuromuscular diseases," said noted pediatrician, human biochemical geneticist and MDA Chairman of the Board R. Rodney Howell, M.D. "With this most recent round of grants, the Association is spurring on the vital science that ultimately will put an end to a litany of devastating muscle diseases."

About the new grants

Of the 44 new awards, 37 will improve understanding of disease pathology for specific neuromuscular diseases (see list of 17 disorders targeted with this new round of MDA grants), or guide development of strategies for better diagnosis and treatment. Please click on any of the following links for investigator-specific releases. Seven italicized links are particularly notable projects:

Alabama
University of Alabama

California
Ludwig Institute
Sanford-Burnham MRI
UC Berkley
UC Los Angeles
UC San Diego 12
UC San Francisco 12
USC

Colorado
University of Colorado

Connecticut
University of Connecticut
Yale University

Florida
University of Miami 12

Georgia
Emory University 12

Iowa
University of Iowa

Maryland
Johns Hopkins 1234

Massachusetts
Brigham & Women's Hosp.
Children's Hospital Boston
Mass General Hospital

Michigan
Michigan State University
University of Michigan

Missouri
University of Missouri

North Carolina
Duke University Med. Ctr.
Carolinas Medical Center

Ohio
Wright State University

Pennsylvania
Temple University
University of Pennsylvania

Tennessee
St. Jude Children's Hosp.

Texas
Baylor College of Medicine

Virginia
University of Virginia

International
Universit Laval, Canada
Lund University, Sweden
Murdoch CRI Australia 12
CERBM GIE, France
University of Rome, Italy

In addition to these 37 research grants, MDA also awarded seven training and development grants designed to increase the number of highly-qualified biomedical researchers working on neuromuscular diseases. Two of these, designated as clinical research training grants (CRTGs), were awarded to promising young physicians James Berry, Massachusetts General Hospital, Boston and Araya Puwanant, University of Rochester, New York. Furthermore, five career development grants were awarded to young neuromuscular disease investigators to facilitate their transition into independent researchers:

"MDA is pleased to support these young investigators and clinical researchers as they embark on their careers," said Valerie Cwik, M.D., MDA Executive Vice President for Research and Medical Director. "These bright physicians and scientists are the future leaders in our quest to defeat muscular dystrophy and related diseases."


'/>"/>

Contact: Lila Petersen
lpetersen@mdausa.org
520-730-9981
Muscular Dystrophy Association
Source:Eurekalert

Related medicine news :

1. European Research Council awards advanced researcher grant to KIT botanist Holger Puchta
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 12 top young scientists
3. Four NYU researchers receive New York Academy of Sciences 2010 Young Scientists awards
4. AAPS presents awards to exemplary researchers
5. InHealth awards grant to research team at Hartford Hospital
6. NCI awards $11.5 million to Fred Hutchinson Cancer Research Center to lead breast cancer consortium
7. National Cancer Institute awards nearly $4 million to University of New Mexico Cancer Center
8. 2010 awards World Cultural Council
9. NIH Recovery Act awards enable crucial health research technologies
10. National Institutes of Health awards $1.2 million to GSU for collaborative study on discharge decisions at hospitals
11. American Cancer Society awards new research and training grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/24/2017)... ... ... Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story about a ... God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” is the ... writing, especially about truth and human behavior. , Published by Christian Faith Publishing, Patti ...
(Date:3/23/2017)... Texas (PRWEB) , ... March 23, 2017 , ... The ... 3rd location in the greater Houston Area. The new location is located at 2255 ... Luke’s Hospital in Springwoods Village. This newest location will provide patients living in the ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets ... the U.S.: Consumer Strategies" report to their offering. ... Pain ... approach and treat their physical pain, emphasizing consumer survey analysis, ... pain sufferers and adults who have selected illnesses/conditions strongly associated ...
(Date:3/24/2017)... , March 24, 2017 ShangPharma, ... high-quality and cost-effective drug development and discovery ... and biotechnology industry, announced today the intent ... ShangPharma will be consolidating the Contract Research ... under Shanghai ChemPartner. These entities include ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: